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An increasing number of SH3 domain–ligand interactions continue to be described that involve the
conserved peptide-binding surface of SH3, but structurally deviate substantially from canonical
docking of consensus motif-containing SH3 ligands. Indeed, it appears that that the relative fre-
quency and importance of these types of interactions may have been underestimated. Instead of
atypical, we propose referring to such peptides as type I or II (depending on the binding orientation)
non-consensus ligands. Here we discuss the structural basis of non-consensus SH3 ligand binding
and the dominant role of the SH3 domain speciﬁcity zone in selective target recognition, and review
some of the best-characterized examples of such interactions.
2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
SH3 domain is a small protein interaction module composed of
a b-sandwich consisting of ﬁve strands connected by three loops
and a short 310 helix (Fig. 1). The pioneering early studies deﬁned
the ligand sequence PxxP as the minimal consensus target site for
SH3 domain binding, and revealed how the PxxP motif is accom-
modated by two distinct xP dipeptide-binding pockets on the
SH3 surface [1,2]. Moreover, it was found that such PxxP motif-
containing peptides could be docked in two opposite orientations
deﬁned by the relative positioning of a positively charged residue
(+xxPxxP or xPxxPx+) interacting with a negatively charged third
cleft on the SH3 peptide-binding surface [3,4]. This third cleft
was named the speciﬁcity pocket. Recognition of these Class I
and Class II consensus SH3 binding motifs has since helped the
identiﬁcation of the interaction partners for many SH3 domains,
and dominated the thinking in this ﬁeld.
However, an increasing number of divergent SH3 domain target
peptides, often referred to as atypical binding motifs, have been
identiﬁed. Thus, it would probably be more appropriate to call such
peptides non-consensus ligands, and to restrict the term atypical for
the less common and fundamentally different interactions that
involve entirely different surfaces on the SH3 domain (for examples,
see [5,6]. Of note, excluding interactions involving additional
tertiary contacts (e.g. Hck-SH3/Nef binding [7]), SH3/ligandal Societies. Published by Elsevier
a).complexes that showunusually strong afﬁnity or distinct selectivity
are usually, if not always, based on a non-consensus binding motif.
Unlike the canonical PxxP motif-based ligands, peptides con-
taining non-consensus SH3 binding motifs do not always adopt a
polyproline type-II (PPII) helical conformation, and may not occupy
both xP-binding pockets of the SH3 domain (see Figs. 2 and 3). On
the other hand, a characteristic feature of the non-consensus mo-
tifs is their extensive use of contacts with the SH3 surface that typ-
ically contains the negatively charged speciﬁcity pocket (see Figs. 2
and 4). Compared to the orientation-deﬁning salt bridges provided
by the speciﬁcity pocket upon Class I and II consensus binding,
elaborate sets of contacts with side chain atoms from several res-
idues in non-consensus ligands can provide signiﬁcant additional
afﬁnity and speciﬁcity to these interactions. Indeed, the role of
such contacts can dominate over those involving the xP-binding
pocket interface of the SH3 domain.
The SH3 surface that contributes to these afﬁnity/speciﬁcity-
determining interactions is formed by a shallow valley above the
b3 and b4 strands, ﬂanked by the far end of strand b2/n-Src loop
and the tip of RT loop (see Fig. 1). In many SH3 domains this sur-
face consists of more than one distinct subpocket, which together
with, or in many cases instead of, a canonical acidic pocket accom-
modate ligand residues located N- or C-terminally (in type I or II
binding, respectively) of the xP-pocket-contacting region of the
peptide (see peptide illustrations in Fig. 2). Because of its structural
complexity and coverage of a large SH3 surface area, we prefer to
use the term speciﬁcity zone to make a clear distinction to the tra-
ditional concept of a speciﬁcity pocket.B.V. Open access under CC BY-NC-ND license. 
Fig. 1. Structural organization of the SH3 domain. Two ribbon models of a typical SH3 domain based on the crystal structure of Sem-5 SH3 are shown above an alignment of
the amino acid sequences of the SH3 domains discussed here. The secondary structure elements of the SH3 fold are indicated above the sequences, and the numbering used
for all SH3 domains in this paper is shown below the alignment. Expect for the Caenorhabditis elegans Sem-5, all sequences are of human origin. Shown in the Sem-5
structures as stick models are the side chains of the key residues that form the two conserved xP pockets (F7 + Y55 and W37 + P52) and the canonical acidic ‘‘speciﬁcity
pocket’’ (E17). The most conserved ligand binding residues are also shown in blue in the alignment, whereas non-conserved residues providing distinct speciﬁcity for a given
SH3 domain are shown in red. In addition, these residues are highlighted in different colors to indicate whether they participate in forming the xP pockets (light blue
background), speciﬁcity zone (pink background), or both (yellow background).
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region and the speciﬁcity zone exhibited by different consensus or
non-consensus ligands are illustrated in Fig. 2. Remarkably, com-
mon sets of molecular contacts with the SH3 speciﬁcity zone have
evolved as modules that can appear in peptides containing a
canonical PPII-helical PxxP motif as well as in peptides that inter-
act with the SH3 xP-pocket region via other strategies.
A striking example of this is provided by the RxxK motif of the
HPK1 and SLP-76 peptides that docks to the speciﬁcity zone of
GADS SH3 domain in a similar manner, despite completely differ-
ent modes of GADS xP-pocket surface recognition by these pep-
tides [12–14]. On the other hand, even in the case of a single
ligand peptide, the modes of xP pocket and speciﬁcity zone recog-
nition can differ between two SH3 domains. This is clearly exem-
pliﬁed by binding of the aminoterminal SH3 domain of Nck and
the Eps8L1 SH3 domain to CD3e [15,16,21]. In both complexes
much of the speciﬁcity and afﬁnity of binding is provided by an
interaction of a DY motif in the ligand with the SH3 speciﬁcity
zone, whereas only Nck SH3 binding involves canonical accommo-
dation of the CD3e peptide as a PPII ligand on the xP pocket surface
of the SH3 domain.
The binding determinants in the ligands that interact with the
SH3 speciﬁcity zone can be quite complex and adopt distinct sec-
ondary structures. Presentation of such speciﬁcity determinantsin the context of a 310 helix can be observed in many cases, includ-
ing the indicated high-afﬁnity interactions of GADS [12–14], Csk
[10], and bPIX SH3 [18–20] domains with their non-consensus li-
gands, whereas the remarkable binding strength (24 nM) of the
carboxyterminal SH3 domain of p67phox with a proline-rich re-
gion of p47phox (another subunit of the NADPH oxidase) depends
on an interaction between a helix-turn-helix structure in the
p47phox ligand with the speciﬁcity zone of the p67phox SH3 do-
main [11]. Some, but not all of these interactions are comple-
mented by canonical ionic interactions between a basic residue
in the ligand an acidic pocket in the speciﬁcity zone of the SH3 do-
main (see Fig. 2).
Interestingly, the PPII helical conformation is not restricted to
the xP-pocket region contacts by the ligands, but is also utilized
for contacts with the speciﬁcity zone [20,21]. An extreme case of
this is the complex between the IRTKS SH3 domain and its ligand
EspFU. This bacterial peptide contains a typical PPII-helical PxxP
motif to interact with the xP pocket region of IRTKS SH3 as a Class
I ligand, but exploits a unique strategy for interacting with the
speciﬁcity zone. The speciﬁcity zone of IRTKS SH3 contains two
hydrophobic clefts, which resemble the xP pockets and accommo-
date the aminoterminal part of the EspFU peptide in a manner that
phenocopies a bona ﬁde PPII-helical PxxP consensus peptide inter-
action [21].
Fig. 2. Diverse strategies for SH3 ligand binding. Peptide conformations observed in a selected set of informative SH3 / ligand structures [3,4,8–21] are schematically shown
together with key data on these interactions. The letters N and C are shown in parentheses after the name of proteins containing two SH3 domains to indicate whether the
amino- or carboxyterminal SH3 is meant. The symbols U and X refer to hydrophobic and aromatic amino acid residues, respectively, whereas ‘‘+’’ is a positively charged
residue (Arg or Lys), and x is any amino acid. Amino acid sequences of the relevant regions of the ligands are shown under the origin of these peptides. The relative orientation
of the peptides in the SH3/ligand complexes is indicated by a plus (+) or a minus (), and also by N and C marking the amino- and carboxytermini of the schematically
illustrated ligand peptides. Since the majority of ligands included in the ﬁgure bind to their cognate SH3 domains as Class II ligands, we have chosen to depict the N-termini of
such minus-orientation peptides as pointing to the left and their C-termini pointing to the right. When a peptide is interacting with the SH3 xP pocket surface as a typical PPII-
helical, the corresponding xPxxP sequence is underlined in the sequence, and depicted in the peptide illustrations as a rounded white box marked PPII. Of note, the EspFU
peptide is using an identical PPII structure also for its interaction with the speciﬁcity zone of the IRTKS SH3 domain. However, in this case the ﬁrst xP pocket in the speciﬁcity
zone is dedicated for binding an IP-dipeptide, thus providing speciﬁcity for this high afﬁnity (500 nM) interaction. On the other hand, some ligands do not form any PPII helix,
and instead interact with the SH3 xP-pocket via very different strategies. When the complex involves an interaction of a canonical positively charged residue of the ligand
with an acidic pocket in the speciﬁcity zone of the SH3 domain, this residue has been colored red in the peptide sequence, and is indicated as a yellow/orange triangle in the
peptide illustration. The orange triangle denotes the special case of the aminoterminal SH3 of the Crk/CrkL proteins. As revealed by the Crk/C3G complex structure these SH3
domains speciﬁcally select Class II ligands with a lysine as the positively charged consensus residue, which they coordinate in an unusual and tight manner by a set of three
acidic SH3 residues [8]. The other residues in the ligand peptides that make key contacts with the SH3 speciﬁcity zone are colored green, and the structural elements
presenting these residues are marked as various colored symbols in the peptide drawings.
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selectivity for SH3 interactions the xP pocket surface can also con-
tribute speciﬁcity for binding. For example, the positioning of the
highly conserved W37 residue is slightly different in SH3 domains
complexed with Class I vs. II consensus ligands. Depending on the
type of residue at position 55 this movement of W37 may be hin-
dered, thereby allowing binding only to Class II peptides or to a
subset of Class I ligands presenting Leu-Pro dipeptides to the SH3
xP pockets [24]. Examples of more distinguishing contacts with
the xP pocket surface can be observed with SH3 ligands that do
not contain PPII helical conformation, such as the complex involv-
ing the bPIX SH3 domain and its target peptide in p21-activated ki-
nase-1 [18] and -2 [19]. Although SH3 domains like GADS (see
Fig. 3) or Fyn [25] may bind both canonical PxxP ligands as well
as non-PPII helical peptides, the anatomy of the xP pockets can fa-
vor one of these. As explained in more detail in the legend for Fig. 3,
this is the case with the SH3 domains of Eps8L1 and GADS, whichprefer non-PPII ligands because of their unusual amino acid
residues in certain conserved xP-pocket-forming positions.
Other informative examples of n-Src loop residue modiﬁcations
that contribute to ligand-speciﬁc contacts at the speciﬁcity zone
are provided by the Csk SH3 in complex with PEP-3BP1 [10] and
the C-terminal SH3 domain of p67phox in complex with p47phox
[11]. In both cases, the ligand peptides bind in the minus-orienta-
tion, and canonical contacts with the SH3 xP pockets and an acidic
pocket in the speciﬁcity zone. However, for additional contacts
with the speciﬁcity zone, both peptides form a helical structure,
although the exact roles of these secondary structures are quite
different. The PEP-3BP1 establishes a 310 helix presenting a hydro-
phobic isoleucine residue that clamps around a ﬁnger in the n-Src
loop formed by K33 of Csk SH3. This interaction is complemented
by a valine in PEP-3BP1 that inserts into a hydrophobic cavity
(circled in yellow) in the speciﬁcity zone of Csk SH3 formed
by A30 and T32. In the case of p67phox–p47phox complex, the
Fig. 3. Examples of combinatorial strategies used by ligands to interact with the xP pockets and speciﬁcity zone surfaces of SH3 domains. SH3 domains are shown using
Coulombic surface presentation, whereas their ligands are shown with a stick model. The key residues in the SH3 domains involved in providing speciﬁcity for these
interactions are indicated using the residues numbering shown in Fig. 1. Hydrophobic xP pockets are circled in yellow, whereas the relevant surfaces of the speciﬁcity zone
are circled in green. The N-terminal SH3 of Nck2 [15] and the SH3 of Eps8L1 [17] are shown in complex with a peptide from the cytoplasmic tail of CD3e. The SH3 domains of
the Eps8 family members as well as the N-terminal SH3 domains of Nck1 and Nck2 bind PxxDY motifs [22,23]. The key interactions, determining the speciﬁcity towards
PxxDY ligands are established between the aspartate residue of the PxxDY motif and a basic SH3 residue in position 35 within the n-Src loop, and between the PxxDY tyrosine
and E17 in an acidic cleft corresponding to the speciﬁcity pocket of archetypal SH3 domains. However, the CD3e peptide is in a PPII conformation when bound to Nck, but in
an extended conformation when bound to Eps8L1. Explaining this, the SH3 of Eps8L1 (like the rest of the Eps8 family) has an isoleucine instead of tyrosine in the conserved
position 55, which renders the shape of the ﬁrst hydrophobic slot different and non-optimal for accommodation of classical XP dipeptide. For this reason, N-terminal SH3
domains of Nck1 and -2 prefer composite class ligands of type xPxUPxxDY, whereas Eps8 SH3 family members can efﬁciently bind ligands of typeUPxxDY [17]. Another pair
of complexes to compare shows peptides from PAK2 and AIP4 in complex with the SH3 domain of the b-PAK-interactive exchange factor (bPIX) [19,20]. Both peptides utilize
the same xP pocket interface of bPIX SH3, but AIP4 binds in Class I whereas PAK2 binds in Class II orientation. Furthermore, AIP4 establishes a canonical PPII conformation and
contacts the SH3 through two xP dipeptides, whereas PAK2 is in an extended conformation and makes contacts through xP and Ile-Ala dipeptides [20]. The third pair of
complexes illustrating the diversity in ligand binding through the xP-pocket interface shows HPK1 and SLP-76 ligands interacting with the SH3 domain of Mona/GADS
[12–14]. Interaction of both peptides with GADS SH3 is driven by an RxxK motif that forms a 310 helical structure and establishes extensive contacts with the negatively
charged E/D residues in a manner resembling classical speciﬁcity pocket interactions. Leucine at position 47 further complements the binding of the RxxK motif. Both
peptides are in Class II orientation, yet in different conformations; HPK1 forms a PPII helix through classical xP dipeptide contacts with the hydrophobic xP pockets of GADS
SH3. By contrast, SLP-76 is in an extended conformation and making contacts through an N-terminal xP dipeptide plus an isoleucine. Nevertheless, SLP-76 exhibits 10-fold
stronger afﬁnity to GADS SH3 in comparison to HPK1. The lower afﬁnity of GADS SH3 towards PPII-helical ligands (such as HPK1) has been attributed to the orientation of the
side chain of its glutamate residue at position 10 [14].
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structure in the speciﬁcity zone p67phox SH3. The critical SH3 res-
idues are I50 in b4 strand and V32 in the n-Src loop that make di-
rect contacts with the a-helices in p47phox peptide.
2. Conclusions and perspectives
Here we deﬁne non-consensus SH3 ligands as peptides that do
not contain a PPII-helical PxxP motif and/or depend on speciﬁcity
determinants more complex than the canonical basic residue of
Class I and II consensus peptides. Instead of an acidic pocket that
accommodates such a basic residue, the speciﬁcity determinants
of non-consensus ligands typically make more extensive contacts
with an overlapping but more complex surface in their cognate
SH3 domains, which we refer as the speciﬁcity zone. Consequently,the binding afﬁnity and selectivity of interactions involving
non-consensus SH3 ligands can be substantially greater than
observed for consensus peptides. On the other hand, from the dis-
tinct and variable nature of such speciﬁcity zone contacts, it also
follows that non-consensus SH3 ligands cannot be readily pre-
dicted from protein sequence data. It is possible that the relative
prevalence of non-consensus ligands is signiﬁcantly higher than
currently appreciated, and the perceived dominance of Class I or
Class II motifs rather reﬂects the historical focus on Src-like pro-
teins in studies leading to the identiﬁcation of the SH3 domain. In-
deed, the majority of the approximately 300 SH3 domains encoded
by the human genome are still lacking a characterized ligand. The
ability to create random peptide libraries of increasing complexity
and peptide length, together with an improved capacity to charac-
terize ligand preferences for a large number of different SH3
Fig. 4. Anatomy of the speciﬁcity zone – ligand interface in selected SH3 domain – peptide complexes. Shown are six different SH3 domains in complex with Class I and II
non-consensus peptides to illustrate contacts in the speciﬁcity zone that enhance afﬁnity and selectivity of SH3 ligand binding. Insulin receptor tyrosine kinase substrate
(IRTKS) SH3 in complex with the pathogen-encoded peptide EspFU [21], Abelson kinase (Abl) SH3 in complex with p41 [9], and bPIX SH3 in complex with AIP4 peptide [20] all
represent Class I interactions (ligand binding in plus-orientation), but their binding preferences are very different. In IRTKS and Abl, the canonical acidic residue at position 17
is replaced by leucine and threonine, respectively, compromising their binding to classical RxxPxxP ligands, whereas bPIX contains a glutamate at position 17, and accordingly
accommodates a typical basic ligand residue in this slot. However, the speciﬁcity zones in Abl, bPIX and IRTKS contain additional slots for enhanced ligand binding speciﬁcity
and afﬁnity. In all these three SH3 domains the ﬁrst additional binding pocket (circled in yellow) is hydrophobic and is established by the highly conserved W37 residue
together with W50 from b4 strand. This pocket interacts with a proline residue in the ligand. The second additional pocket found in IRTKS and bPIX (circled in green) helps to
further increase their ligand binding speciﬁcity. Hydrophobic residues rarely encountered at the tip of b2 strand and in b3 strand (positions 30 and 39) render this second
pocket in IRTKS highly hydrophobic, and strongly favors docking of an IP dipeptide. Thus, through the combined action of the two hydrophobic pockets in the speciﬁcity zone
and the two canonical xP pockets IRTKS speciﬁcally recognizes peptide ligands with the consensus IPxXPxxxXPxXP [21]. By contrast in bPIX the position 39 contributing to
the second speciﬁcity zone pocket is negatively charged by glutamate, and accommodates a positively charged arginine of the AIP4 peptide [20]. Nevertheless, as already
discussed in the case of xP pocket usage in Fig. 3, bPIX SH3 binds also non-consensus Class II ligands, and forms 310 helix upon interaction with the speciﬁcity zone, as
highlighted for bPIX SH3 – PAK2 complex [19].
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shed more light into this question (see [26–28]). Finally, while
mediating tight and speciﬁc contacts with SH3 ligands, the com-
plex and variable surface of the speciﬁcity zone also has much
more potential for drug targeting than the ﬂat, hydrophobic, and
structurally conserved xP pockets. Therefore, the speciﬁcity zone
should be considered a prime target in the efforts to develop phar-
macological inhibitors against disease processes mediated by SH3
domain–guided protein interactions.
References
[1] Ren, R., Mayer, B.J., Cicchetti, P. and Baltimore, D. (1993) Identiﬁcation of a ten-
amino acid proline-rich SH3 binding site. Science 259, 1157–1161.
[2] Yu, H., Chen, J.K., Feng, S., Dalgarno, D.C., Brauer, A.W. and Schreiber, S.L.
(1994) Structural basis for the binding of proline-rich peptides to SH3
domains. Cell 76, 933–945.
[3] Feng, S., Chen, J.K., Yu, H., Simon, J.A. and Schreiber, S.L. (1994) Two binding
orientations for peptides to the Src SH3 domain: development of a general
model for SH3–ligand interactions. Science 266, 1241–1247.[4] Lim, W.A., Richards, F.M. and Fox, R.O. (1994) Structural determinants of
peptide-binding orientation and of sequence speciﬁcity in SH3 domains.
Nature 372, 375–379.
[5] Barnett, P., Bottger, G., Klein, A.T., Tabak, H.F. and Distel, B. (2000) The
peroxisomal membrane protein Pex13p shows a novel mode of SH3
interaction. EMBO J. 19, 6382–6391.
[6] Nishida, M., Nagata, K., Hachimori, Y., Horiuchi, M., Ogura, K., Mandiyan, V.,
Schlessinger, J. and Inagaki, F. (2001) Novel recognition mode between Vav
and Grb2 SH3 domains. EMBO J. 20, 2995–3007.
[7] Lee, C.H., Saksela, K., Mirza, U.A., Chait, B.T. and Kuriyan, J. (1996) Crystal
structure of the conserved core of HIV-1 Nef complexed with a Src family SH3
domain. Cell 85, 931–942.
[8] Wu, X., Knudsen, B., Feller, S.M., Zheng, J., Sali, A., Cowburn, D., Hanafusa, H.
and Kuriyan, J. (1995) Structural basis for the speciﬁc interaction of lysine-
containing proline-rich peptides with the N-terminal SH3 domain of c-Crk.
Structure 3, 215–226.
[9] Pisabarro, M.T., Serrano, L. and Wilmanns, M. (1998) Crystal structure
of the abl-SH3 domain complexed with a designed high-afﬁnity
peptide ligand: implications for SH3–ligand interactions. J. Mol. Biol.
281, 513–521.
[10] Ghose, R., Shekhtman, A., Goger, M.J., Ji, H. and Cowburn, D. (2001) A novel,
speciﬁc interaction involving the Csk SH3 domain and its natural ligand. Nat.
Struct. Biol. 8, 998–1004.
2614 K. Saksela, P. Permi / FEBS Letters 586 (2012) 2609–2614[11] Kami, K., Takeya, R., Sumimoto, H. and Kohda, D. (2002) Diverse recognition of
non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and
Pex13p. EMBO J. 21, 4268–4276.
[12] Lewitzky, M., Harkiolaki, M., Domart, M.C., Jones, E.Y. and Feller, S.M. (2004)
Mona/Gads SH3C binding to hematopoietic progenitor kinase 1 (HPK1)
combines an atypical SH3 binding motif, R/KXXK, with a classical PXXP motif
embedded in a polyproline type II (PPII) helix. J. Biol. Chem. 279, 28724–28732.
[13] Harkiolaki, M., Lewitzky, M., Gilbert, R.J., Jones, E.Y., Bourette, R.P.,
Mouchiroud, G., Sondermann, H., Moareﬁ, I. and Feller, S.M. (2003)
Structural basis for SH3 domain-mediated high-afﬁnity binding between
Mona/Gads and SLP-76. EMBO J. 22, 2571–2582.
[14] Liu, Q., Berry, D., Nash, P., Pawson, T., McGlade, C.J. and Li, S.S. (2003) Structural
basis for speciﬁc binding of the Gads SH3 domain to an RxxK motif-containing
SLP-76 peptide: a novel mode of peptide recognition. Mol. Cell 11, 471–481.
[15] Takeuchi, K., Yang, H., Ng, E., Park, S.Y., Sun, Z.Y., Reinherz, E.L. and Wagner, G.
(2008) Structural and functional evidence that Nck interaction with
CD3epsilon regulates T-cell receptor activity. J. Mol. Biol. 380, 704–716.
[16] Santiveri, C.M., Borroto, A., Simon, L., Rico, M., Alarcon, B. and Jimenez, M.A.
(2009) Interaction between the N-terminal SH3 domain of Nck-alpha and
CD3-epsilon-derived peptides: non-canonical and canonical recognition
motifs. Biochim. Biophys. Acta 1794, 110–117.
[17] Aitio, O., Hellman, M., Kesti, T., Kleino, I., Samuilova, O., Paakkonen, K.,
Tossavainen, H., Saksela, K. and Permi, P. (2008) Structural basis of PxxDY
motif recognition in SH3 binding. J. Mol. Biol. 382, 167–178.
[18] Mott, H.R., Nietlispach, D., Evetts, K.A. and Owen, D. (2005) Structural analysis
of the SH3 domain of beta-PIX and its interaction with alpha-p21 activated
kinase (PAK). Biochemistry 44, 10977–10983.
[19] Hoelz, A., Janz, J.M., Lawrie, S.D., Corwin, B., Lee, A. and Sakmar, T.P. (2006)
Crystal structure of the SH3 domain of betaPIX in complex with a high afﬁnity
peptide from PAK2. J. Mol. Biol. 358, 509–522.[20] Janz, J.M., Sakmar, T.P. and Min, K.C. (2007) A novel interaction between
atrophin-interacting protein 4 and beta-p21-activated kinase-interactive
exchange factor is mediated by an SH3 domain. J. Biol. Chem. 282, 28893–
28903.
[21] Aitio, O., Hellman, M., Kazlauskas, A., Vingadassalom, D.F., Leong, J.M., Saksela,
K. and Permi, P. (2010) Recognition of tandem PxxP motifs as a unique Src
homology 3-binding mode triggers pathogen-driven actin assembly. Proc.
Natl. Acad. Sci. USA 107, 21743–21748.
[22] Kesti, T., Ruppelt, A., Wang, J.H., Liss, M., Wagner, R., Tasken, K. and Saksela, K.
(2007) Reciprocal regulation of SH3 and SH2 domain binding via tyrosine
phosphorylation of a common site in CD3epsilon. J Immunol 179, 878–885.
[23] Mongiovi, A.M., Romano, P.R., Panni, S., Mendoza, M., Wong, W.T., Musacchio,
A., Cesareni, G. and Di Fiore, P.P. (1999) A novel peptide–SH3 interaction.
EMBO J. 18, 5300–5309.
[24] Fernandez-Ballester, G., Blanes-Mira, C. and Serrano, L. (2004) The tryptophan
switch: changing ligand-binding speciﬁcity from type I to type II in SH3
domains. J. Mol. Biol. 335, 619–629.
[25] Kang, H., Freund, C., Duke-Cohan, J.S., Musacchio, A., Wagner, G. and Rudd, C.E.
(2000) SH3 domain recognition of a proline-independent tyrosine-based
RKxxYxxY motif in immune cell adaptor SKAP55. EMBO J. 19, 2889–2899.
[26] Ernst, A., Gfeller, D., Kan, Z., Seshagiri, S., Kim, P.M., Bader, G.D. and Sidhu, S.S.
(2010) Coevolution of PDZ domain–ligand interactions analyzed by high-
throughput phage display and deep sequencing. Mol. BioSyst. 6, 1782–1790.
[27] Tonikian, R., Zhang, Y., Sazinsky, S.L., Currell, B., Yeh, J.H., Reva, B., Held, H.A.,
Appleton, B.A., Evangelista, M., Wu, Y., et al. (2008) A speciﬁcity map for the
PDZ domain family. PLoS Biol. 6, e239.
[28] Yip, K.Y., Utz, L., Sitwell, S., Hu, X., Sidhu, S.S., Turk, B.E., Gerstein, M. and Kim,
P.M. (2011) Identiﬁcation of speciﬁcity determining residues in peptide
recognition domains using an information theoretic approach applied to
large-scale binding maps. BMC Biol. 9, 53.
